Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
暂无分享,去创建一个
H. Liu | S. Janssens | M. Takata | F. Ichinose | K. Bloch | D. Bloch | G. Filippov | Heling Liu | H. Liu | Kenneth D. Bloch | Donald B. Bloch | Masao Takata | Fumito Ichinose | Stefan Janssens
[1] J Zhang,et al. Nitric oxide synthase assays. , 2001, Current protocols in pharmacology.
[2] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[3] J. Koistinaho,et al. Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. , 1999, Gene.
[4] D. Nakayama,et al. Escherichia coliLipopolysaccharide Downregulates Soluble Guanylate Cyclase in Pulmonary Artery Smooth Muscle , 1998 .
[5] D. Nakayama,et al. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle. , 1998, The Journal of surgical research.
[6] K. Bloch,et al. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. , 1997, The Journal of clinical investigation.
[7] M. Nakane,et al. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. , 1997, The American journal of physiology.
[8] K. Bloch,et al. Nerve Growth Factor Decreases Soluble Guanylate Cyclase in Rat Pheochromocytoma PC12 Cells* , 1997, The Journal of Biological Chemistry.
[9] F. Murad,et al. Downregulation of nitrovasodilator‐induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin‐1β , 1996, British journal of pharmacology.
[10] J. Cobb,et al. Nitric oxide and septic shock. , 1996, JAMA.
[11] F. Murad,et al. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells , 1996, British journal of pharmacology.
[12] F. Murad,et al. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. , 1995, Hypertension.
[13] R. McIntyre,et al. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. , 1995, The American journal of physiology.
[14] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[15] Carl Nathan,et al. Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.
[16] R. Star,et al. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells. , 1994, The Journal of pharmacology and experimental therapeutics.
[17] S. Janssens,et al. cAMP regulates soluble guanylate cyclase beta 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. , 1993, The American journal of physiology.
[18] F. Murad,et al. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. , 1990, The Journal of biological chemistry.
[19] B. Fanburg,et al. Endothelial cell inhibition of hypoxia-induced stimulation of serotonin uptake by vascular smooth muscle cells. , 1989, The American review of respiratory disease.
[20] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[21] S. Klöss,et al. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. , 2000, Hypertension.
[22] D. Nakayama,et al. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. , 1998, The Journal of surgical research.
[23] C. K. Mittal. [25] Determination of adenylate cyclase and guanylate cyclase activities in cells of the immune system , 1986 .
[24] C. K. Mittal. Determination of adenylate cyclase and guanylate cyclase activities in cells of the immune system. , 1986, Methods in enzymology.